As of 2025-05-03, the Intrinsic Value of Max Healthcare Institute Ltd (MAXHEALTH.NS) is 314.99 INR. This MAXHEALTH.NS valuation is based on the model Discounted Cash Flows (Growth Exit 5Y). With the current market price of 1,089.80 INR, the upside of Max Healthcare Institute Ltd is -71.10%.
The range of the Intrinsic Value is 245.53 - 445.68 INR
Based on its market price of 1,089.80 INR and our intrinsic valuation, Max Healthcare Institute Ltd (MAXHEALTH.NS) is overvalued by 71.10%.
Range | Selected | Upside | |
a | |||
DCF (Growth 5y) | 245.53 - 445.68 | 314.99 | -71.1% |
DCF (Growth 10y) | 415.67 - 762.55 | 536.73 | -50.7% |
DCF (EBITDA 5y) | 613.42 - 888.70 | 760.54 | -30.2% |
DCF (EBITDA 10y) | 830.17 - 1,334.39 | 1,076.99 | -1.2% |
Fair Value | 259.33 - 259.33 | 259.33 | -76.20% |
P/E | 228.00 - 579.66 | 392.97 | -63.9% |
EV/EBITDA | 297.97 - 493.89 | 373.93 | -65.7% |
EPV | 53.05 - 71.28 | 62.16 | -94.3% |
DDM - Stable | 61.65 - 148.71 | 105.18 | -90.3% |
DDM - Multi | 233.65 - 445.60 | 307.32 | -71.8% |
Market Cap (mil) | 1,059,438.10 |
Beta | 1.42 |
Outstanding shares (mil) | 972.14 |
Enterprise Value (mil) | 1,064,257.00 |
Market risk premium | 8.31% |
Cost of Equity | 13.03% |
Cost of Debt | 11.88% |
WACC | 12.99% |